Impact of obesity on women's health

Fertility and Sterility

Volumn 91, Issue 5, 2009, Pages 1712-1716

  Lash, Marcy Maguire ^a   Armstrong, Alicia ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

anovulation; ART; contraception; dysfunctional uterine bleeding; infertility; miscarriage; Obesity; puberty

Indexed keywords

FOLLITROPIN; INSULIN; LUTEINIZING HORMONE;

ARTICLE; CONTRACEPTION; DISEASE ASSOCIATION; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; METRORRHAGIA; MORBIDITY; MORTALITY; NONHUMAN; OBESITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; UNITED STATES; WEIGHT REDUCTION;

CONTRACEPTION; FEMALE; FERTILITY; HUMANS; MENSTRUATION; OBESITY; PUBERTY; REPRODUCTIVE MEDICINE; REPRODUCTIVE TECHNIQUES, ASSISTED; WOMEN'S HEALTH;

EID: 67349283006     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.02.141     Document Type: Article

References (40)

1. O'Brien P.E., and Dixon J.B. The extent of the problem of obesity. Am J Surg 184 6B (2002) 4S-8S
2. National Highway Traffic Safety Information. Available at: http://www.nhtsa.gov.
3. Centers for Disease Control. Available at: www.cdc.gov/hiv/stats.htm.
4. Hensrud D.D., and Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc 81 10 suppl (2006) S5-S10
5. Wyatt H.R. The prevalence of obesity. Prim Care 30 (2003) 267-279
6. Smith S.C., Clark L.T., Cooper R.S., Daniels S.R., Kumanyika S.K., Ofili E., et al. Discovering the full spectrum of cardiovascular disease, Minority Health Summit 2003: Report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) e134-e139
7. Rosenberg T.J., Garbers S., Chavkin W., and Chiasson M.A. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population. Obstet Gynecol 102 (2003) 1022-1027
8. Must A., Naumova E.N., Phillips S.M., Blum M., Dawson-Hughes B., and Rand W.M. Childhood overweight and the maturational timing in the development of adult overweight and fatness: the Newton Girls Study and its follow-up. Pediatrics 116 (2005) 620-627
9. Himes J.H. Examining the evidence for recent secular changes in the timing of puberty in U.S. children in light of increases in the prevalence of obesity. Mol Cell Endocrinol 254-5 (2006) 12-13
10. Kaltila-Heino R., Kosunen E., and Rimpela M. Pubertal timing, sexual behavior and self-reported depression in middle adolescence. J Adolesc 26 (2003) 531-545
11. Frisch R.E., and Revelle R. Height and weight at menarche and a hypothesis of menarche. Arch Dis Child 48 (1971) 695-701
12. Frisch R.E., and McArthur J.W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 185 (1974) 949-951
13. Ahemed M.L., Ong K., Morrel D., Cox L., Drayer N., Perry L., et al. Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab 84 (1999) 899-905
14. Ahima R.S., Dushay J., Flier S.N., Prabakaran D., and Flier J.S. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 99 (1997) 391-395
15. Tang T., Glanville J., Hayden C.J., White D., Barth J.H., and Balen A.H. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 21 (2006) 80-89
16. Essah P.A., Apridonidze T., Iuorno M.J., and Nestler J.E. Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril 86 (2006) 230-232
17. Eisenhardt S., Schwarzmann N., Henschel V., Germeyer A., von Wolff M., Hamann A., et al. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 91 (2006) 946-952
18. ESHRE Capri Work Group. Nutrition and reproduction in women. Hum Reprod Update 12 (2006) 193-207
19. Smallwood G.H., Meador M.L., Lenihan J.P., Shangold G.A., Fisher A.C., Creasy G.W., and ORTHO EVRA/EVRA 002 Study Group. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 98 (2001) 799-805
20. Koetsawang S., Ji G., Krishna U., Cuadros A., Dhall G., Wyss R., et al. Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial: III. The relationship between pregnancy and body weight. Contraception 41 (1990) 143-150
21. Burkman R., Schlesselman J.J., and Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 190 (2004) S5-S22
22. Abdollahi M., Cushman M., and Rosendaal F.R. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 89 (2003) 493-498
23. Hammoud AO, Gibson M, Hunt SC, Carrell D, Adams TD, Meikle W. Effect of weight loss after Roux-en-Y gastric by-pass surgery on the male reproductive profile. 63rd Annual Meeting of the American Society for Reproductive Medicine, Washington, DC, October 2007, Abstract O-3.
24. Lord J.M., Flight I.H., and Norman R.J. Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3 (2003) CD003053
25. Ramlau-Hansen C.H., Thulstrup A.M., Nohr E.A., Bonde J.P., Sorensen T.I.A., and Olsen J. Subfecundity in overweight and obese couples. Hum Reprod 22 (2007) 1634-1637
26. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
27. Barash I.A., Cheung C.C., Weigle D.S., Ren H., Kabigting E.B., Kuijper J.L., et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 137 (1996) 3144-3147
28. Chehab F.F., Lim M.E., and Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12 (1996) 318-320
29. Lashen H., Fear K., and Sturdee D.W. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 19 (2004) 1644-1646
30. Fedorcsak P., Storeng R., Dale P.O., Tanbo T., and Abyholm T. Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance. Gynecol Endocrinol 14 (2000) 327-336
31. Kawamura K., Sato N., Fukuda J., Kodama H., Kumagai J., Tanikawa H., et al. The role of leptin during the development of mouse preimplantation embryos. Mol Cell Endocrinol 202 (2003) 185-189
32. Castellucci M., De Matteis R., Meisser A., Cancello R., Monsurro V., Islami D., et al. Leptin Modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod 6 (2000) 951-958
33. Bellver J., Melo M., Bosch E., Serra V., Remohi J., and Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Stertil 88 (2007) 446-451
34. Bellver J., Rossal L.P., Bosch E., Zuniga A., Corona J.T., Melendez F., et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 79 (2003) 1136-1140
35. Arnett CM, Huang JQ, Rosenwaks Z, Spandorfer SD. Spontaneous abortion in donor oocyte recipients: the risk associated with extremes of body mass. 63rd Annual Meeting of the American Society for Reproductive Medicine, Washington, DC, October 2007, Abstract O-173.
36. Dokras A., Baredziak L., Blaine J., Syrop C., VanVoorhis B.J., and Sparks A. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol 108 (2006) 61-69
37. Fedorcsak P., Dale P.O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19 (2004) 2523-2528
38. Imani B., Eijkemans M.J., Faessen G.H., Bouchard P., Giudice L.C., and Fauser B.C. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril 77 (2002) 83-90
39. Norman R.J., Noakes M., Wu R., Davies M.J., Mora L., and Wang J.X. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 10 (2004) 267-280
40. Jauniaux E., Farquharson R.G., Christiansen O.B., and Exalto N. Evidence-based guidelines for investigation and medical management of recurrent miscarriage. Hum Reprod 21 (2006) 2216-2222